SCD5 and neoplasm: Analysis of KEGG pathway showed that SCD5 was involved in peroxisome proliferator-activated receptor (PPAR) and AMP-activated protein kinase (AMPK) signaling pathways (Table 2), which were related to the inhibition of the multiplication of tumor cell.